Table 1.
Age Group (yr) | Number at Risk | Prevalence (%)1 (95% CI) |
---|---|---|
Men 21-34 35-44 45-54 55-64 65-84 |
1483 73 414 566 324 106 |
11.9 (10.3, 13.6) 9.6 (4.1, 17.6) 10.6 (7.7, 13.6) 11.1 (8.5, 13.7) 13.9 (10.1, 17.7) 17.0 (9.8, 24.1) |
Women 21-34 35-44 45-54 55-64 65-84 |
1784 106 516 659 384 119 |
9.4 (8.1, 10.8) 10.4 (4.6, 16.2) 7.2 (4.9, 9.4) 7.4 (5.4, 9.4) 14.6 (11.1, 18.1) 12.6 (6.7, 18.6) |
Both sexes 21-34 35-44 45-54 55-64 65-84 |
3267 179 930 1225 708 225 |
10.6 (9.5, 11.6) 10.1 (5.7, 14.5) 8.7 (6.9, 10.5) 9.1 (7.5, 10.8) 14.3 (11.7, 16.9) 14.7 (10.1, 19.3) |
Linear trends in prevalence by age group were statistically significant for men, women, and both sexes (Mantel-Haenszel Chi-Square test, p < .05).